Clinical Trial

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

Recruiting
View on ClinicalTrials.gov →
Summary
The efficacy and safety of anti-inflammation treatment (Hirudoid introduction followed by yellow light therapy) combined with tofacitinib and doxycycline in Chinese adult patients with mild to moderate erythematous telangiectatic rosacea: A prospective parallel controlled single-blind cohort study
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2026-03-20
Trial Details
NCT Number NCT07343635
Lead Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions Erythematotelangiectatic Rosacea
Enrollment 186 participants
Start Date 2026-02-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-24